A comprehensive view of novavax inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
South Sudan Commences Child Immunization with R21/Matrix-M™ Malaria Vaccine in Public Health Milestone
Published:
July 19, 2024
by Industry Intelligence Inc.
|
First-ever doses of R21/Matrix-M™ Malaria Vaccine administered in Cote d’Ivoire; partners include UNICEF, Gavi, WHO, University of Oxford, and Serum Institute of India
Published:
July 16, 2024
by Industry Intelligence Inc.
|
Novavax Inc. enhances global health via partnerships, policy events on COVID-19; company collaborates with US embassies in Paris, Madrid, and Italy to improve vaccination for vulnerable groups
Published:
July 11, 2024
by Industry Intelligence Inc.
|
Novavax submits application to Health Canada for updated 2024-2025 COVID-19 vaccine; the protein-based vaccine would be the only such option if authorized, targeting JN.1 variants
Published:
July 02, 2024
by Novavax Inc.
|
CDC's ACIP votes unanimously for universal recommendation of 2024-2025 COVID-19 vaccines for individuals 6 months and older; Novavax plans to provide doses pending EUA by FDA
Published:
June 27, 2024
by Novavax Inc.
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count